Assessment of the extent of surgical resection as a predictor of survival in patients with primary osseous spinal neoplasms

Clinical Neurosurgery

Volumn 58, Issue , 2011, Pages 117-121

  Chaichana, Kaisorn L ^a   Parker, Scott L ^a   Mukherjee, Debraj ^a   Cheng, Joseph S ^a   Gokaslan, Ziya L ^a   McGirt, Matthew J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RESEARCH; CHONDROSARCOMA; CHORDOMA; CLINICAL ASSESSMENT; CONFERENCE PAPER; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SPINE CANCER; SPINE CHONDROSARCOMA; SPINE CHORDOMA; SPINE OSTEOSARCOMA; SPINE SURGERY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR LOCALIZATION; ADOLESCENT; AGED; ARTICLE; CHILD; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SARCOMA; SPINAL CORD TUMOR;

ADOLESCENT; ADULT; AGED; CHILD; CHORDOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOMA; SEER PROGRAM; SPINAL NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 80155174116     PISSN: 00694827     EISSN: 0148396X     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318226fff7     Document Type: Conference Paper

References (38)

1. Facts and figures. 2008. http://www.americancancersociety.org. Accessed November 19, 2008.
2. Sciubba DM, Okuno SH, Dekutoski MB, Gokaslan ZL. Ewing and osteogenic sarcoma: evidence for multidisciplinary management. Spine (Phila Pa 1976). 2009;34(22)(suppl):S58-S68.
3. Dorfman HD, Czerniak B. Bone cancers. Cancer. 1995;75(1)(suppl):203-210.
4. Bovill EG Jr, Kung'u A, Bencivenga A, Jeshrani MK, Mbindyo BS, Heda PM. An epidemiological study of osteogenic sarcoma in Kenya: the variations in incidence between ethnic groups and geographic regions, 1968-1978. Int Orthop. 1985;9(1):59-63. (Pubitemid 15058514)
5. Larsson SE, Lorentzon R. The incidence of malignant primary bone tumours in relation to age, sex and site: a study of osteogenic sarcoma, chondrosarcoma and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg Br. 1974;56B(3):534-540.
6. Oyemade GA, Abioye AA. Primary malignant tumors of bone: incidence in Ibadan, Nigeria. J Natl Med Assoc. 1982;74(1):65-68. (Pubitemid 12151060)
7. Price CH, Jeffree GM. Incidence of bone sarcoma in SW England, 1946-74, in relation to age, sex, tumour site and histology. Br J Cancer. 1977;36(4):511-522. (Pubitemid 8203669)
8. Sundaresan N, Rosen G, Boriani S. Primary malignant tumors of the spine. Orthop Clin North Am. 2009;40(1):21-36, v.
9. Ozaki T, Flege S, Liljenqvist U, et al. Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer. 2002;94(4):1069-1077. (Pubitemid 34150862)
10. Shives TC, Dahlin DC, Sim FH, Pritchard DJ, Earle JD. Osteosarcoma of the spine. J Bone Joint Surg Am. 1986;68(5):660-668. (Pubitemid 16073917)
11. Sundaresan N, Rosen G, Huvos AG, Krol G. Combined treatment of osteosarcoma of the spine. Neurosurgery. 1988;23(6):714-719. (Pubitemid 19018772)
12. Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91(7):1201-1212. (Pubitemid 32267029)
13. Boriani S, De Iure F, Bandiera S, et al. Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976). 2000;25(7):804-812.
14. Shives TC, McLeod RA, Unni KK, Schray MF. Chondrosarcoma of the spine. J Bone Joint Surg Am. 1989;71(8):1158-1165. (Pubitemid 19262364)
15. York JE, Berk RH, Fuller GN, et al. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 1999;90(1)(suppl):73-78. (Pubitemid 29037137)
16. Evans RG, Nesbit ME, Gehan EA, et al. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. J Clin Oncol. 1991;9(7):1173-1180.
17. Grubb MR, Currier BL, Pritchard DJ, Ebersold MJ. Primary Ewing's sarcoma of the spine. Spine (Phila Pa 1976). 1994;19(3):309-313.
18. Marco RA, Gentry JB, Rhines LD, et al. Ewing's sarcoma of the mobile spine. Spine (Phila Pa 1976). 2005;30(7):769-773.
19. Paulino AC, Nguyen TX, Mai WY. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007;48(4):423-429. (Pubitemid 46340108)
20. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122-2134. (Pubitemid 30233215)
21. Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976). 2006;31(4):493-503.
22. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma: prognostic factors and treatment. Spine (Phila Pa 1976). 1999;24(16):1639-1645.
23. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12(1):1-11. (Pubitemid 32125896)
24. York JE, Kaczaraj A, Abi-Said D, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44(1):74-79.
25. Hsieh PC, Xu R, Sciubba DM, et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976). 2009;34(20):2233-2239.
26. Arai Y, Kun LE, Brooks MT, et al. Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21(6):1501-1508.
27. Bacci G, Boriani S, Balladelli A, et al. Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J. 2009;18(8):1091-1095.
28. Fourney DR, Rhines LD, Hentschel SJ, et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine. 2005;3(2):111-122.
29. Ito E, Saito K, Okada T, Nagatani T, Nagasaka T. Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir (Wien). 2010;152(1):57-67.
30. Weber KL. Current concepts in the treatment of Ewing's sarcoma. Expert Rev Anticancer Ther. 2002;2(6):687-694. (Pubitemid 35469491)
31. Gherlinzoni F, Picci P, Bacci G, Campanacci D. Limb sparing versus amputation in osteosarcoma: correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol. 1992;3(suppl 2):S23-S27.
32. Link MP, Goorin AM, Horowitz M, et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity: updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991(270):8-14.
33. DeLaney TF, Park L, Goldberg SI, et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005;61(2):492-498. (Pubitemid 40164446)
34. Marmor E, Rhines LD, Weinberg JS, Gokaslan ZL. Total en bloc lumbar spondylectomy: case report. J Neurosurg. 2001;95(2)(suppl):264-269. (Pubitemid 33730852)
35. Rao G, Suki D, Chakrabarti I, et al. Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine. 2008;9(2):120-128.
36. Navid F, Willert JR, McCarville MB, et al. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer. 2008;113(2):419-425.
37. Stacchiotti S, Marrari A, Tamborini E, et al. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009;20(11):1886-1894.
38. Wagner LM, McAllister N, Goldsby RE, et al. Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer. 2007;48(2):132-139. (Pubitemid 44958268)